Medicare Enrolled

Dr. Gerald Goltz, M.D.

Nephrology · Sewickley, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
701 BROAD ST STE 421, Sewickley, PA 15143
4127412552
In practice since 2006 (20 years)
NPI: 1720033244 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Goltz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Goltz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Goltz

Dr. Gerald Goltz is a nephrology specialist in Sewickley, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Goltz performed 1,098 Medicare services across 581 unique beneficiaries.

Between the years covered by Open Payments, Dr. Goltz received a total of $61,626 from 50 pharmaceutical and/or device companies across 731 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Goltz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 37% volume in PA $61,626 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,098
Medicare services
Top 37% in PA for nephrology
581
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~55 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
791 $79 $165
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
87 $61 $125
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
72 $25 $75
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
65 $49 $125
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
33 $77 $215
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
20 $100 $225
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
16 $10 $45
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
14 $109 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$61,626
Total received (2018-2024)
Avg $8,804/year across 7 years
Top 4% in PA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
731
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$53,717 (87.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,909 (12.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,150
2023
$1,916
2022
$1,846
2021
$7,817
2020
$7,534
2019
$20,948
2018
$19,415

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$505
Novo Nordisk Inc
$217
Dexcom, Inc.
$179
Bayer Healthcare Pharmaceuticals Inc.
$169
Xeris Pharmaceuticals, Inc.
$155
Amgen Inc.
$154
Medtronic, Inc.
$92
BETA BIONICS, INC.
$81
Tandem Diabetes Care, Inc.
$73
Boehringer Ingelheim Pharmaceuticals, Inc.
$72
Verity Pharmaceuticals Inc.
$59
Chiesi USA, Inc.
$49
Astellas Pharma US Inc
$44
Amphastar Pharmaceuticals, Inc.
$43
Antares Pharma, Inc.
$39
Amneal Pharmaceuticals LLC
$39
Abbott Laboratories
$38
Madrigal Pharmaceuticals
$29
Averitas Pharma Inc.
$27
Insulet Corporation
$24
PFIZER INC.
$19
Radius Health, Inc.
$16
Neurocrine Biosciences, Inc.
$15
TheracosBio, LLC
$11
Top 3 companies account for 41.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$49,082
Insulet Corporation
$4,195
Lilly USA, LLC
$1,732
Medtronic MiniMed, Inc.
$1,527
Amgen Inc.
$518
Dexcom, Inc.
$471
Xeris Pharmaceuticals, Inc.
$356
AstraZeneca Pharmaceuticals LP
$332
Abbott Laboratories
$283
Boehringer Ingelheim Pharmaceuticals, Inc.
$281
SANOFI-AVENTIS U.S. LLC
$248
Bayer Healthcare Pharmaceuticals Inc.
$228
Tandem Diabetes Care, Inc.
$215
Becton, Dickinson and Company
$210
Bayer HealthCare Pharmaceuticals Inc.
$171
Amarin Pharma Inc.
$147
Amneal Pharmaceuticals LLC
$141
Embecta Corp.
$141
Medtronic, Inc.
$119
Antares Pharma, Inc.
$116
IBSA Pharma Inc.
$108
BETA BIONICS, INC.
$81
Radius Health, Inc.
$71
Corcept Therapeutics
$61
MannKind Corporation
$61
Verity Pharmaceuticals Inc.
$59
Chiesi USA, Inc.
$49
Astellas Pharma US Inc
$44
Amphastar Pharmaceuticals, Inc.
$43
PFIZER INC.
$42
AbbVie Inc.
$42
ABBVIE INC.
$42
Supernus Pharmaceuticals, Inc.
$36
Horizon Therapeutics plc
$34
LIFESCAN, INC.
$33
Madrigal Pharmaceuticals
$29
Janssen Pharmaceuticals, Inc
$28
Averitas Pharma Inc.
$27
Merck Sharp & Dohme Corporation
$26
Mannkind Corporation
$25
AbbVie, Inc.
$24
Valeritas, Inc.
$23
DEXCOM, INC.
$21
Zealand Pharma US, Inc.
$19
CeQur Corporation
$19
Novartis Pharmaceuticals Corporation
$16
Alexion Pharmaceuticals, Inc.
$15
Neurocrine Biosciences, Inc.
$15
Currax Pharmaceuticals LLC
$14
TheracosBio, LLC
$11
Top 3 companies account for 89.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Brenzavvy · CeQur Simplicity · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FIASP · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LICART · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NOCDURNA · NovoLog · ONZETRA XSAIL · Omnipod · Ozempic · QUTENZA · RECORLEV · RESMETIROM · RETEVMO · RYBELSUS · Repatha · Rybelsus · SOLIQUA 100/33 · SOMAVERT · SYNTHROID · Saxenda · Strensiq · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tlando · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Veozah · Victoza · Wegovy · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in nephrology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for nephrology in PA.

Looking for a nephrology specialist in Sewickley?
Compare nephrologists in the Sewickley area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
78
Per 100K population
6.3
County median income
$76,393
Nearest hospital
HERITAGE VALLEY SEWICKLEY
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Goltz is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 4% of PA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Goltz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Goltz performed 791 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Goltz receive payments from pharmaceutical companies?
Yes. Dr. Goltz received a total of $61,626 from 50 companies across 731 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Goltz's costs compare to other nephrologists in Sewickley?
Dr. Goltz's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Goltz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →